12 January 2021 A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Non-Pancreatic Neuroendocrine Tumors. View PDF
Recent News Neuroendocrine Cancer UK launches NCUK Academy Nurse Course CALLING ALL MEMBERS – CAST YOUR VOTE! UK Oncology Forum – 21st -22nd October Registration open now for KHP NET Centre 8th Annual Meeting UKI NETS 19th Annual Conference 2021 – Terms and Conditions of Virtual Event Participation
Sign up for our newsletterSign-up for our email newsletter. Simply give us your email address in the box below to sign-up.Email
